Search

Search Constraints

You searched for: Author/Creator Stoops, Erik

Search Results

2. [P1–237]: DIFFERENTIAL ROLE OF CSF FATTY ACID BINDING PROTEIN 3, α‐SYNUCLEIN AND ALZHEIMER's DISEASE CORE BIOMARKERS IN LEWY BODY DISORDERS AND ALZHEIMER's DEMENTIA. (1st July 2017)

4. [P1–280]: ANALYTICAL PERFORMANCE CHARACTERISTICS OF A NOVEL IMMUNOASSAY FOR THE QUANTIFICATION OF BACE‐1 IN HUMAN CEREBROSPINAL FLUID. (1st July 2017)

5. [P2–238]: ANALYTICAL PERFORMANCE CHARACTERISTICS OF A PROTOTYPE IMMUNOASSAY FOR QUANTIFICATION OF ALPHA‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID. (1st July 2017)

6. [P3–248]: PLASMA AMYLOID BETA LEVELS, CEREBRAL SMALL‐VESSEL DISEASES AND COGNITION: THE ROTTERDAM STUDY. (1st July 2017)

7. [P4–151]: ALPHA‐SYNUCLEIN BIOMARKER ANALYSIS: ANALYTICAL PERFORMANCE AND INTER‐LABORATORY PRECISION USING A NEW COLORIMETRIC ELISA. (1st July 2017)

8. [P4–152]: DIFFERENCES IN ANALYTICAL SELECTIVITY OF β‐AMYLOID (1–42) IMMUNOASSAYS EXPLAIN DISCORDANT RESULTS IN STUDY COMPARISONS. (1st July 2017)

9. [P4–394]: ASSOCIATIONS OF PLASMA AMYLOID BETA LEVELS WITH SEVERITY AND PROGRESSION OF CEREBRAL SMALL VESSEL DISEASE. (1st July 2017)

10. [P4–468]: PROGRESS ON THE DEVELOPMENT OF CERTIFIED REFERENCE MATERIALS FOR Aβ1–42. (1st July 2017)